Outlook 2020 Teleconference: Washington, D.C. Updates and Insights on Life Sciences and Health Care

January 30, 2020
Albert F. Cacozza, Jr.
Kellie B. Combs , Gregory H. Levine , Beth P. Weinman ,
Thomas N. Bulleit
Samantha Barrett Badlam

On Thursday, January 30,  Ropes & Gray hosted a teleconference on regulatory, compliance and enforcement updates for life sciences and health care companies. The discussion featured the perspectives of FDA regulatory partners Al Cacozza, Kellie Combs and Greg Levine FDA regulatory counsel, Beth Weinman, health care partner Tom Bulleit and litigation and enforcement counsel Samantha Barrett Badlam. The program examined various issues, including: 

  • Health Care –prescription drug pricing, surprise billing, provider pricing transparency, value-based healthcare  
  • Developments at the FDA - new FDA commissioner, medical devices, biosimilars, real world evidence, big data and digital health
  • Enforcement update – FDA key areas of enforcement, DOJ enforcement priorities, Anti-Kickback Statue, Foreign Corrupt Practices Act (FCPA)

To listen to a recording of the teleconference, please click here.

To access the teleconference transcript, please click here.